Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT103A in Relapsed/Refractory Multiple Myeloma
NCT05066646Phase 2Unknown
- Sponsor
- Reindeer Biotech
- Start
- Apr 2020
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluconazole in multiple myeloma (MM), sponsored by Reindeer Biotech. Status: unknown.
02
Drugs
fluconazole
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05066646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066646.